Apelin

DB18909InvestigationalProtein Based Therapies

Apelin is under investigation in clinical trial NCT03449251 (A Series of Pilot Studies to Evaluate the Haemodynamic and Metabolic Effects of Apelin and Relaxin).

Mechanism: Pharmacologically active on Apelin receptor
Curator reviewed
Code names: APLN

Resolves to

Compound

UNII7P5ZL6T59YCAS372170-33-7

Targets

P35414APLNR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

11Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Apelin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account